AtriCure, Inc. ATRC
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus
Chart by TradingView
7/9
Piotroski F — financial health
3.44
Altman Z″ — distress risk · safe
—
Dividend payout · no dividend
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2025 | $534.5M | -$11.4M | $400.8M | $48.3M | $491.9M |
| 2024 | $465.3M | -$44.7M | $347.5M | $745,000 | $461.0M |
| 2023 | $399.2M | -$30.4M | $300.4M | -$7.5M | $466.2M |
| 2022 | $330.4M | -$46.5M | $245.9M | -$39.0M | $456.8M |
| 2021 | $274.3M | $50.2M | $205.9M | -$23.5M | $483.8M |
| 2020 | $206.5M | -$48.2M | $149.3M | -$25.1M | $412.4M |
Recent insider activity (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| Prange Karen | director | 2026-05-20 | Sell | 3,000 | $28.65 |
| Prange Karen | director | 2026-05-18 | Grant | 6,144 | — |
| Telman Deborah H | director | 2026-05-18 | Grant | 6,144 | — |
| Yuen Maggie | director | 2026-05-18 | Grant | 6,144 | — |
| Nachman Shlomo | director | 2026-05-18 | Grant | 6,144 | — |
| JOHNSON B KRISTINE | director | 2026-05-18 | Grant | 6,144 | — |
| GROVES REGINA E | director | 2026-05-18 | Grant | 6,144 | — |
| WEHRWEIN SVEN | director | 2026-05-18 | Grant | 6,144 | — |
Why these scores methodology →
Piotroski F-score: 7/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 3.44 (safe)
- Working capital / assets 0.368
- Retained earnings / assets -0.632
- EBIT / assets -0.014
- Equity / liabilities 3.032
Source: SEC EDGAR filings · CIK 0001323885 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.